Abstract To describe the circulation dynamics of human rotavirus genotypes in a region of southern Europe over a 13-year period. The G-and P-types of rotavirus isolates of patients aged less than 5 years were analyzed using multiplex, reverse transcription polymerase-chain reaction. Of 1,538 isolates investigated, a combination of individual G-and P-types was obtained in 1,368. The most prevalent combination was G1[P8] (57.5% of the genotyped strains), which circulated in all seasons and predominated in nine out of 13 seasons. The strains
Introduction
Human group A rotavirus is the main cause of severe acute gastroenteritis (AGE) among children worldwide. Approximately half a million children are estimated to die each year from rotavirus AGE, mostly in developing countries [1] . In developed countries, this disease also has a substantial impact due to the high number of hospitalizations, outpatient and emergency department visits, and family costs it provokes [2] [3] [4] . Two oral vaccines, Rotarix® (GlaxoSmithKline Biologicals, Rixensart, Belgium) and RotaTeq® (Merck and Company, Whitehouse Station, NJ, USA), have shown good efficacy in preventing rotavirus disease [5, 6] . These vaccines have recently been introduced into the immunization schedules of some countries [5, 7] and are being considered for inclusion by many others. Rotarix contains an attenuated strain of a human rotavirus genotype G1[P8], while RotaTeq includes strains from five human-bovine reassortant rotaviruses, expressing the human G-types G1-G4 and the human P-type P [8] , respectively [5] .
Rotavirus contains two structural proteins, VP4 and VP7, which induce the synthesis of neutralizing antibodies, codified in two genetic segments that can segregate independently and which form the basis of the classification system, based on G (VP7) and P (VP4) types [8] . Given the variety of existing rotavirus genotypes, the frequency with which they undergo genetic reassortment and the occasional transmission of animal rotaviruses to humans [9, 10] , circulating genotypes must be monitored to detect the emergence of new or unusual strains that could spread geographically and compromise the effectiveness of vaccination programs [5, 9] . This article presents the results of rotavirus G-and P-typing over a 13-year period in children in the Basque Country (Spain).
Materials and methods

Study population
This prospective study was performed in the regions of San Sebastián, Tolosa and Urola-Costa (Basque Country, northern Spain), with 405,745 inhabitants, of which 19,738 were aged less than 5 years, according to the municipal censuses for 2006 (Basque Institute of Statistics), representing 20.6% of the pediatric population of the Basque Country. The study included all patients aged less than 5 years who sought medical care for AGE in our region and for whom stool cultures were requested, both from the hospital and from the outpatient clinics in the study area, between July 1996 and June 2009. Duplicate episodes occurring in the same semester were not included. Among hospitalized children, infections in which the stool samples were obtained 5 days or more after hospital admission were considered to be nosocomial. Rotarix was commercialized in Spain in July 2006 and in RotaTeq in February 2007. Neither of these two vaccines (which are not subsidized) have been included in the Basque Health System vaccination calendar, and the mean coverage for both vaccines in the last 2 years of the study was estimated to be less than 30%.
Virological studies
The presence of group A rotavirus antigen in stool was investigated with a commercial enzyme immunoassay (EIA) kit, following the manufacturer's instructions (IDEIA™ Rotavirus, Dako Diagnostics Ltd., Ely, Cams, UK). Samples with remaining material in which EIA provided the highest optical density (>2000) were suspended in phosphate buffered saline or B199 medium (Sigma-Aldrich, St Louis MO, USA), frozen at −80°C and subsequently analyzed for G-and P-type through multiplex, reverse transcription (RT)-polymerase chain reaction (PCR) methods [10] from 2006 onwards. Viral RNA was obtained with an automatic BioRobot® M48 extractor (Qiagen GmbH, Hilden, Germany) using the MagAttact® Virus Mini M48 kit or the NucliSENS® Easy-Mag platform (bio-Mèrieux SA, Marcy l'Etoile, France). Transcription of RNA to cDNA was performed with M-MuLV reverse transcriptase (USB Corp., Cleveland, OH, USA), using random hexamers. Each PCR run included a negative control (water control), which was treated identically to the clinical samples throughout the experiment. Samples in which no amplicon was obtained with this genotyping method were reassayed with the same primers but using the Qiagen Multiplex PCR Kit (Qiagen, GmbH, Hilden, Germany) (n=135). All procedures were performed with routine precautions to avoid contamination. In selected cases, i.e. unusual G-types, the amplicons obtained were sequenced, using an AbiPrism 3100 Genetic Analyser (Applied Biosystems, Foster City, CA, USA).
Nucleotide sequence accession numbers VP7 and VP4 partial sequences of some unusual strains (G6[P14], G8[P14] and G12[P8]) found in this study were deposited in the GenBank database under accession numbers GU563713-GU563720.
Statistical analysis
The chi-square test was used to compare the proportions of rotavirus-positive children. Analysis of variance was used to compare the ages of children infected with distinct rotavirus genotypes. Significance was set at α=5%.
Results
Characterization of rotavirus infection episodes
During the study period, 50,115 stool samples from children aged less than 5 years with AGE were obtained. Rotavirus was detected in 5,131 (10.2%), corresponding to 4,870 AGE episodes occurring in 4,816 children (2,688 boys and 2,128 girls). The seasonal distribution of rotavirus AGE episodes for each year of the study can be seen in Fig. 1 . A total of 546 episodes occurred in infants aged less than 6 months (11.2%), 1,438 (29.5%) in infants aged 6 to <12 months and 1,920 (39.4%) in children aged 12 to <24 months. Among community-acquired rotavirus AGE episodes (n=4,752), 437 required hospitalization (9.2%). A further 118 (2.4%) episodes of rotavirus infection occurred in children hospitalized for other reasons.
Genotypes G-and P-types were investigated in the samples of 1,538 rotavirus AGE episodes. Both types were obtained in 1,368 samples (88,9%, 91.9% including mixed infections) and the G-type was obtained in 1,438 (93.5%) ( Table 1 ). Cocirculation of more than one G-type was a constant finding throughout the study, although one or two predominated in each season. The combination of G-and P-types most frequently detected in the 13 years of the study was rotavirus G1[P8] (57.5%, 786/1368), dominating in nine seasons and circulating in all (Table 2) . To better illustrate circulation of rotavirus genotypes in the Basque Country, Fig. 2 shows data on the G-type (G1-G4) obtained through serotyping in this region between 1989 and 1995 [11] . Rotavirus G9[P8] (13.4%) was detected sporadically from rotaviruses circulated widely in the first triennium of the study (27.8%, 65/234) and were predominant in the 1997-1998 epidemic, but represented only 0.9% (10/1134) of the strains genotyped after July 1999. Unusual G-types (G6, G8, G12) were detected in seven episodes (0.5%, six confirmed by sequencing, one G12 not sequenced) and unusual combinations of common G-and P-types, especially G1[P4] and G2[P8], were observed in eight episodes (0.6%). Mixed infections with more than one G-type were uncommon (n=45, 2.9%). A total of 150 rotavirus AGE episodes in which G-and P-types were studied occurred in children hospitalized for AGE due to rotavirus. We found no differences in hospitalization due to distinct genotypes, or in the age at which the infection occurred ( Table 2 ).
Discussion
This study shows the dynamics of rotavirus G-and P-types circulation over 13 consecutive epidemics in children in the Basque Country (Spain). The data from this study, together with those from a previous study [11] , provide information on 20 years of monitoring of rotavirus G-types (July 1989-June 2009, 2802 strains studied) (Fig. 2) . The burden of rotavirus disease on the health care system was substantial during the study period, despite a remarkable decrease in the incidence of rotavirus AGE observed in the first decade of this century [12] . In line with the results of previous studies performed in developed countries in recent years, we observed predominant circulation of G1[P8] strains, the emergence of G9[P8] strains, and scarce detection of Gtype strains other than G1-G4 and G9 [2, 9, [13] [14] [15] . In 14 of the 20 seasons after 1989, the main G-type was G1, a percentage similar to that also observed over a 20-year period (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) in Palermo, Italy [16] . G1 caused more than half of the infections genotyped and showed significant circulation in all epidemics. In contrast, circulation of the remaining genotypes, especially G2, G3 and G4, was intermittent and was undetectable for varying periods (1-3 years). The predominance of G1 strains could be due to the wide genetic and antigenic heterogeneity of the population of strains of this genotype [16] .
Rotavirus seasons. In Europe, sporadic detection of G9 strains was reported in Italy in the first half of the 1990s [17] . However, after the emergence of the new lineage 3 in the United States in 1993-1994, G9 strains spread throughout the world and became a common genotype globally [9] . In Europe, the new strains were initially detected in the United Kingdom (1995-1996) combined with P-type 6, which was replaced by P-type 8 in the next few years [18] A well-documented finding in this survey was the marked decrease in the current decade in the circulation of the G4 genotype. This genotype circulated widely in our environment in the 1990s but only sporadically after 1999, in line with prior reports in Spain [22] but in contrast with reports from other European regions [2, 22, [24] [25] [26] .
We detected few infections with unusual combinations of G-and P-types, notable combinations being the G1[P4] and G2[P8] genotypes, which represented 0.6% of the genotyped episodes. These genotypes were probably secondary to reassortment among co-circulating human genotypes [18, 27] and were also the most frequent unusual combinations found in other regions [9, 15, 18, 26] . The origin of these recombinant viruses probably lies in mixed infections, which were also infrequent in our study (2.9%). Three strains belonging to G-types 6 (G6[P14]) and 8 (G8[P8] and G8 [P14]) were detected. G6 and G8 strains are frequently found in bovine cattle [9] and are rarely detected in human infections in Europe [14, 15, 18, 21, 25, 26] . Human [P14] rotavirus strains have been reported exceptionally across the globe and probably represent occasional interspecies transmission from ruminants [28] . Likewise, we detected G-type 12 strains, which have recently spread throughout the world and are increasingly identified in Europe [14, 25, 29] . Of the 1,538 rotavirus strains investigated, 6.5% could not be G-and P-typed, a percentage that could be expected from the results of other studies [9, 12] .
The percentage of strains from hospitalized patients was similar for the distinct G-types; consequently, differences in their aggressivity seems unlikely [2, 25] . Greater pathogenicity has been associated with some genotypes [30, 31] , which is currently a cause of controversy. This greater pathogenicity could be related to the introduction of new strains against which the population lacks immunity [31] and could therefore be transitory. The pattern of circulating genotypes shows continental and subcontinental variations, which could be important when predicting the potential impact of vaccination [9, 13, 15] . In the Basque Country, a G-type and/or a P-type was included in the monovalent and pentavalent vaccines for 85.4% and 99.8% of the genotyped strains, respectively; when the simultaneous presence of the Gand P-types contained in the vaccines was considered, these percentages were 57.5% and 71.6%.
In conclusion, G1-G4 and G9 represented >99% of the circulating rotaviruses in the Basque Country between 1996 and 2009. G-type 1 strains predominated (57.5%), circulating significantly in all epidemics. Co-circulation of more 
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G2 G3 G4 G9 Cases/10000 inhabitants Fig. 2 Percent distribution of the main rotavirus G-types (G1-G4 and G9) in children aged less than 5 years with acute gastroenteritis due to rotavirus in the regions of San Sebastián, Tolosa and Urola-Costa (Basque Country, Spain) in 20 consecutive seasons. The distribution from July 1989-June 1996 was studied by serotyping (G1-G4 types, see reference 11) and between July 1996 and June 2009 by genotyping (G1-G4 and G9 types, present study). The percentage of strains that could not be G-typed was 22% with serotyping and 6.5% with genotyping. The continuous line (referring to the secondary axis) represents the incidence of rotavirus infection (antigenpositive cases) in children aged less than 5 years than one genotype was normal, one of which occasionally became dominant for one or two seasons, in fluctuations that are currently unpredictable. Other G-types, such as G6, G8 and G12, as well as reassortment of common G-and P-types, were detected occasionally. In view of the circulating genotypes in this region and the changes produced over time, vaccine efficacy can be expected to be high. However, after the introduction of vaccination, rotavirus surveillance should be maintained due to the high genetic variability of this virus.
